ALFRED E MANN FOUNDATION FOR SCIENTIFIC RESEARCH: Form 990, tax year 2022

View the entire original 990 at ProPublica ↗

Organization
ALFRED E MANN FOUNDATION FOR SCIENTIFIC RESEARCH (EIN 95-4002032)
Tax period
2022-04-01 to 2023-03-31
Filed
2023-07-28
IRS object ID
202312099349301756
Schema version
2022v5.0
Source
Download XML · Original 990 at ProPublica

Every field in the e-filed return. Faint text is the IRS element name, for citing.

Return header ReturnHeader

FieldValueIRS element (for citing)
Return2023-07-28T16:05:48-05:00ReturnTs
Tax Period End2023-03-31TaxPeriodEndDt

Preparer Firm PreparerFirmGrp

FieldValueIRS element (for citing)
Preparer Firm EIN910189318PreparerFirmEIN

Preparer Firm Name PreparerFirmName

FieldValueIRS element (for citing)
Business Name Line1MOSS ADAMS LLPBusinessNameLine1Txt

Preparer US Address PreparerUSAddress

FieldValueIRS element (for citing)
Address Line121700 OXNARD ST STE 300AddressLine1Txt
CityWOODLAND HILLSCityNm
State AbbreviationCAStateAbbreviationCd
ZIP91367ZIPCd
FieldValueIRS element (for citing)
Return Type990ReturnTypeCd
Tax Period Begin2022-04-01TaxPeriodBeginDt

Filer Filer

FieldValueIRS element (for citing)
EIN954002032EIN

Business Name BusinessName

FieldValueIRS element (for citing)
Business Name Line1THE ALFRED E MANN FOUNDATION FORBusinessNameLine1Txt
Business Name Line2SCIENTIFIC RESEARCHBusinessNameLine2Txt
FieldValueIRS element (for citing)
Business Name ControlALFRBusinessNameControlTxt
Phone6617026700PhoneNum

US Address USAddress

FieldValueIRS element (for citing)
Address Line125134 RYE CANYON LOOPAddressLine1Txt
CitySANTA CLARITACityNm
State AbbreviationCAStateAbbreviationCd
ZIP91355ZIPCd

Business Officer BusinessOfficerGrp

FieldValueIRS element (for citing)
PersonROBERT GREENBERGPersonNm
Person TitleCEOPersonTitleTxt
Phone6617026700PhoneNum
Signature2023-07-28SignatureDt
Discuss With Paid PreparerYes (1)DiscussWithPaidPreparerInd

Signing Officer SigningOfficerGrp

Person Full Name PersonFullName

FieldValueIRS element (for citing)
Person FirstROBERTPersonFirstNm
Person LastGREENBERGPersonLastNm
FieldValueIRS element (for citing)
SSN999009999SSN
FieldValueIRS element (for citing)
IRS Responsible Prty Info Curr0IRSResponsiblePrtyInfoCurrInd

Preparer Person PreparerPersonGrp

FieldValueIRS element (for citing)
Preparer PersonWENDY CAMPOSPreparerPersonNm
PTINP00448102PTIN
Phone8185771900PhoneNum
Preparation2023-07-27PreparationDt

Additional Filer Information AdditionalFilerInformation

Trusted Customer TrustedCustomerGrp

FieldValueIRS element (for citing)
Trusted Customer2TrustedCustomerCd
Authentication Assurance LevelAAL1AuthenticationAssuranceLevelCd
Identity Assurance LevelIAL1IdentityAssuranceLevelCd
FieldValueIRS element (for citing)
Tax2022TaxYr
Build TS2023-04-26 12:10:37ZBuildTS

Form 990 IRS990

FieldValueIRS element (for citing)
Principal OfficerROBERT GREENBERGPrincipalOfficerNm

US Address USAddress

FieldValueIRS element (for citing)
Address Line125134 RYE CANYON LOOPAddressLine1Txt
CitySANTA CLARITACityNm
State AbbreviationCAStateAbbreviationCd
ZIP91355ZIPCd
FieldValueIRS element (for citing)
Gross Receipts$33,535,258GrossReceiptsAmt
Group Return For Affiliates0GroupReturnForAffiliatesInd
Organization501c3Yes (X)Organization501c3Ind
Website AddressWWW.AEMF.ORGWebsiteAddressTxt
Type Of Organization CorpYes (X)TypeOfOrganizationCorpInd
Formation1985FormationYr
Legal Domicile StateCALegalDomicileStateCd
Activity Or MissionCONDUCT MEDICAL AND SCIENTIFIC RESEARCHActivityOrMissionDesc
Voting Members Governing Body5VotingMembersGoverningBodyCnt
Voting Members Independent4VotingMembersIndependentCnt
Total Employee84TotalEmployeeCnt
Total Volunteers4TotalVolunteersCnt
Total Gross UBI$0TotalGrossUBIAmt
Net Unrelated Bus Txbl Incm$0NetUnrelatedBusTxblIncmAmt
PY Contributions Grants$721,081PYContributionsGrantsAmt
CY Contributions Grants$805CYContributionsGrantsAmt
PY Program Service Revenue$1,059,040PYProgramServiceRevenueAmt
CY Program Service Revenue$862,321CYProgramServiceRevenueAmt
PY Investment Income$120,224,737PYInvestmentIncomeAmt
CY Investment Income$28,018,820CYInvestmentIncomeAmt
PY Other Revenue$6,533,970PYOtherRevenueAmt
CY Other Revenue$2,172,096CYOtherRevenueAmt
PY Total Revenue$128,538,828PYTotalRevenueAmt
CY Total Revenue$31,054,042CYTotalRevenueAmt
PY Grants And Similar Paid$5,000PYGrantsAndSimilarPaidAmt
CY Grants And Similar Paid$5,000CYGrantsAndSimilarPaidAmt
PY Benefits Paid To Members$0PYBenefitsPaidToMembersAmt
CY Benefits Paid To Members$0CYBenefitsPaidToMembersAmt
PY Salaries Comp Emp Bnft Paid$11,812,035PYSalariesCompEmpBnftPaidAmt
CY Salaries Comp Emp Bnft Paid$13,688,082CYSalariesCompEmpBnftPaidAmt
PY Total Prof Fndrsng Expns$0PYTotalProfFndrsngExpnsAmt
CY Total Prof Fndrsng Expns$0CYTotalProfFndrsngExpnsAmt
CY Total Fundraising Expense$0CYTotalFundraisingExpenseAmt
PY Other Expenses$6,325,662PYOtherExpensesAmt
CY Other Expenses$9,129,152CYOtherExpensesAmt
PY Total Expenses$18,142,697PYTotalExpensesAmt
CY Total Expenses$22,822,234CYTotalExpensesAmt
PY Revenues Less Expenses$110,396,131PYRevenuesLessExpensesAmt
CY Revenues Less Expenses$8,231,808CYRevenuesLessExpensesAmt
Total Assets BOY$374,343,975TotalAssetsBOYAmt
Total Assets EOY$344,680,217TotalAssetsEOYAmt
Total Liabilities BOY$2,647,791TotalLiabilitiesBOYAmt
Total Liabilities EOY$5,996,723TotalLiabilitiesEOYAmt
Net Assets Or Fund Balances BOY$371,696,184NetAssetsOrFundBalancesBOYAmt
Net Assets Or Fund Balances EOY$338,683,494NetAssetsOrFundBalancesEOYAmt
Info In Schedule O Part IIIYes (X)InfoInScheduleOPartIIIInd
MissionTHE ALFRED E. MANN FOUNDATION FOR SCIENTIFIC RESEARCH IS A MEDICAL RESEARCH ORGANIZATION DEDICATED TO DEVELOPING AND COMMERCIALIZING INNOVATIVE SOLUTIONS FOR SIGNIFICANT UNMET MEDICAL CONDITIONS.MissionDesc
Significant New Program Srvc0SignificantNewProgramSrvcInd
Significant Change0SignificantChangeInd
Expense$12,353,374ExpenseAmt
Grant$5,000GrantAmt
Revenue$0RevenueAmt
DescIMPLANTABLE NEUROMODULATION PROJECT TO TREAT CHRONIC DISEASE THE AIM OF THE AMF PROGRAM IS TO DEVELOP A NEUROSTIMULATION SYSTEM THAT WILL IMPROVE MEDICAL OUTCOMES AT A LOWER COST AND/OR HIGHER PATIENT SATISFACTION THAN CURRENTLY AVAILABLE TREATMENT OPTIONS. SUCH A SYSTEM WILL CONSIST OF A FULLY IMPLANTABLE NEURAL STIMULATOR FOR SEAMLESS OPERATION AND REQUIRING MINIMAL INTERACTION FROM A PATIENT, WITH THE GOAL OF OFFERING A HIGHER LEVEL OF PATIENT SATISFACTION, ADOPTION, AND COMPLIANCE.STATUS:PLANNING, DESIGN, AND DEVELOPMENT OF THE FIRST-IN-HUMAN IMPLANT AND EXTERNALS HAVE BEEN INITIATED AND ARE WELL UNDER WAY; SEVERAL NON-SIGNIFICANT RISK CLINICAL STUDIES ARE UNDERWAY OR COMPLETED, INCLUDING A STUDY AT UCLA, ONE CONDUCTED BY HARVEY MUDD COLLEGE, AND AN INTERNAL VOLUNTEER STUDY. PRE-CLINICAL STUDIES HAVE ALSO BEEN CONDUCTED.Desc

Prog Srvc Accom Acty2 ProgSrvcAccomActy2Grp

FieldValueIRS element (for citing)
Expense$3,606,557ExpenseAmt
Revenue$2,172,692RevenueAmt
DescNEW PROJECT DEVELOPMENTTHIS PROGRAM COVERS (A) THE MONITORING AND EVALUATION OF SEVERAL EARLY STAGE ADVANCED RESEARCH AND DEVELOPMENT EFFORTS UNDERWAY THAT ARE DIRECTED AT DEVELOPING ADVANCED TECHNOLOGIES, PROJECT IDEAS AND CONCEPTS BEFORE THEY ARE ELEVATED TO THE STATUS OF FULL-FLEDGED DEVELOPMENT PROGRAMS, AND (B) ONGOING EFFORTS RELATED TO THE ADVANCEMENT OF COMMERCIAL DEVELOPMENT AND PROTECTION OF INTELLECTUAL PROPERTY OF THESE PROJECTS ACROSS THE DEVELOPMENT LIFECYCLE. THE TEAM COMPRISES THE FULL RANGE OF EXPERTISE AVAILABLE AT AMF, INCLUDING SENIOR EXECUTIVE MANAGEMENT, RESEARCH SCIENTISTS AND ENGINEERS, LEGAL AND INTELLECTUAL PROPERTY EXPERTS, BUSINESS DEVELOPMENT STRATEGISTS AND ANALYSTS.EXPENSES MAY INCLUDE ONGOING PARTICIPATION IN THE DEVELOPMENT EFFORT INCLUDING RESEARCH AND DEVELOPMENT SUPPORT, COLLABORATION MANAGEMENT, CONFERENCE AND PROFESSIONAL SOCIETY MEETING ATTENDANCE, SERVICE IN MANAGEMENT OR ON THE BOARD OF DIRECTORS OF SPINOUT ENTITIES, PATENT PROSECUTION AND THE PROSECUTION OF INFRINGEMENT ACTIONS TO PROTECT THE VALUE OF THE INTELLECTUAL PROPERTY WE CREATE. IN ADDITION TO PAYROLL EXPENSES AND DIRECT EXPENSES PAID TO OUTSIDE VENDORS FOR GOODS AND SERVICES RELATED TO PROJECTS, EXPENSES IN THIS PROGRAM MAY INCLUDE TRAVEL EXPENSES, PATENT PROSECUTION EXPENSES AND FEES, LEGAL FEES (FOR INTERNAL AND OUTSIDE LEGAL COUNSEL) FOR EXPENSES TO CREATE, PRESERVE AND PROTECT INTELLECTUAL PROPERTY FROM INFRINGEMENT AND REMEDY PAST INFRINGEMENT, AND INCENTIVE AND OTHER COMPENSATION PAYMENTS TO EMPLOYEES AND OTHERS RELATED TO THESE PROGRAMS AND ACTIONS. IN SOME CASES, CERTAIN OF THESE EXPENDITURES MIGHT BE INCURRED LONG AFTER THE PROJECTS HAVE BEEN LAUNCHED INTO SPINOUT COMPANIES OR LICENSED TO THIRD PARTIES.REVENUES ASSOCIATED WITH THESE PROJECTS (SOME OF WHICH MAY ACCRUE LONG AFTER THE PROJECT AND ANY RELATED PROGRAM HAVE BEEN OUT-LICENSED OR LAUNCHED INTO A SPINOUT COMPANY) MAY INCLUDE RECOVERIES OF JUDGMENTS OR SETTLEMENTS FROM PATENT INFRINGEMENT LITIGATION, ROYALTIES ON NET SALES OF LICENSED PRODUCTS, MILESTONE PAYMENTS, ONGOING CONTRACT R&D FROM PARTNERS, LICENSEES AND SPINOUT COMPANIES, INTEREST, AND PROCEEDS OF LIQUIDITY EVENTS (E.G., INITIAL PUBLIC OFFERINGS, ACQUISITIONS) INVOLVING RETAINED EQUITY INTERESTS IN PROJECTS THAT HAVE BEEN SPUN OUT INTO STARTUP COMPANIES.STATUS:PRELIMINARY DESIGN ACTIVITIES BEGAN FOR A NEW BIOELECTRONIC PROGRAM BASED ON THE BUSINESS CASE ANALYSIS CONDUCTED IN THE PRIOR YEAR. THESE ACTIVITIES INCLUDED GENERATION OF INITIAL SYSTEM REQUIREMENTS, ASSEMBLY OF A TEAM OF KEY OPINION LEADERS WITH DOMAIN EXPERTISE, AND THE INITIATION OF SOME FUNDAMENTAL APPLIED RESEARCH IN THE AREA OF NOVEL ELECTRODE DESIGN, INCLUDING POTENTIAL PRE-CLINICAL TESTING. ADDITIONALLY, THE BUSINESS DEVELOPMENT TEAM, ALONG WITH EXECUTIVE MANAGEMENT AND OTHER STAFF, PERFORMED PRELIMINARY DUE DILIGENCE ON A NUMBER OF ASSETS.Desc

Prog Srvc Accom Acty3 ProgSrvcAccomActy3Grp

FieldValueIRS element (for citing)
Expense$2,097,482ExpenseAmt
Revenue$701,650RevenueAmt
DescIMPLANTABLE MYOELECTRIC SENSOR II (IMES INFINITY) + OSSURTHE TECHNOLOGY HAS BEEN LICENSED TO OSSUR AND IS IN DESIGN AND MANUFACTURING TRANSFER.STATUS: ADDITIONAL ANALYSIS AND DEVELOPMENT WORK WAS DONE TO PREDICT FEASIBILITY OF THE USE OF THE DEVICE ON LOWER LIMBS; THE PRODUCT WAS TRANSFERRED TO A COMMERCIAL PARTNER (OSSUR) INCLUDING DOCUMENTATION OF ALL ELEMENTS OF THE UPPER LIMB PRODUCT; BUILD OF INITIAL CLINICAL IMES INFINITY UNITS WAS COMPLETED AT AMF. DESIGN TRANSFER SUPPORT ACTIVITIES WERE ALSO CONDUCTED.Desc

Prog Srvc Accom Acty Other ProgSrvcAccomActyOtherGrp (3 entries)

ExpenseExpenseAmtRevenueRevenueAmtDescDesc
$701,541$0OTHER PROJECT STATUS:SEVERAL STUDIES ARE PLANNED TO EXPLORE THE FEASIBILITY OF USING AMF'S TECHNOLOGY FOR OTHER APPLICATIONS. THESE STUDIES INCLUDE AN INTERNAL NSR STUDY, PRE-CLINICAL STUDIES, AND COMPUTER SIMULATION STUDIES. ADDITIONALLY, THE SOFTWARE FOR AMF'S TECHNOLOGY IS BEING DEVELOPED WITH FLEXIBILITY TOWARDS OTHER APPLICATIONS.
$106,038$103,615IMPLANTABLE DRUG PUMPSINCE 2019 AMF HAS SEARCHED FOR SUITABLE APPLICATIONS AND PARTNERS TO DEVELOP THE IDP FURTHER IN CERTAIN FIELDS OF USE REQUIRING DRUG DELIVERY FOR CHRONIC CONDITIONS. THE IDP IS A SOPHISTICATED, HIGHLY PROGRAMMABLE DRUG INFUSION DEVICE THAT IS IMPLANTED IN THE BODY AND REFILLED VIA A HYPODERMIC NEEDLE THROUGH THE SKIN. INFUSION RATES AND SCHEDULES MAY BE PROGRAMMED, AND VIA VARIOUS FORMS OF CATHETERS, DRUGS CAN BE DELIVERED INTRATHECALLY TO THE SPINAL COLUMN, INTO THE ABDOMEN, INTO THE BRAIN, OR INTRAVENOUSLY. STATUS: AMF HAS SOLD THE IDP TECHNOLOGY TO MEDTRONIC DIABETES. AMF CONTINUES TO SUPPORT MEDTRONIC AS IT WORKS TO ADAPT THE DESIGN FOR DIABETES BY DELIVERING INSULIN TO THE ABDOMEN IN AND READY IT FOR COMMERCIALIZATION FOR THE BENEFIT OF PATIENTS WITH HARD-TO-TREAT TYPE 1 DIABETES. WORK TO DATE HAS BEEN PROMISING.
$47,955$56,470ORION AMF IS SUPPORTING THE DEVELOPMENT OF A NEW, GROUNDBREAKING VISUAL CORTICAL PROSTHESIS FOR THE PARTIAL RESTORATION OF VISION TO PATIENTS SUFFERING FROM DISORDERS SUCH AS DIABETIC RETINOPATHY, GLAUCOMA, OR TRAUMA TO THE EYES OR OPTIC NERVE. IT IS A FULLY IMPLANTABLE, NEURAL-INTERFACE SYSTEM CAPABLE OF ELECTRICALLY STIMULATING THE HUMAN VISUAL CORTEX AND RESTORING VISUAL PERCEPTION TO PROFOUNDLY BLIND PATIENTS WHO TODAY HAVE NO OTHER TREATMENT OPTIONS. THIS HIGH-DENSITY CORTICAL STIMULATION PROSTHESIS, CALLED THE ORION CORTICAL VISUAL PROSTHESIS, HAS AN ARRAY SPECIFICALLY DESIGNED FOR THE VISUAL CORTEX. THE GOAL OF THIS PROJECT IS TO INVESTIGATE THE PERFORMANCE OF THE CORTICAL PROSTHESIS THROUGH AN IDE EARLY FEASIBILITY HUMAN CLINICAL TRIAL.STATUS:INITIAL CLINICAL TRIAL RESULTS IN THE FIRST PATIENTS ARE ENCOURAGING; AMF HAS BEEN KEY IN THE PROGRAM MANAGEMENT BY PROVIDING ACCESS TO ONE OF THE PRINCIPAL INVESTIGATORS.
FieldValueIRS element (for citing)
Total Other Prog Srvc Expense$855,534TotalOtherProgSrvcExpenseAmt
Total Other Prog Srvc Revenue$160,085TotalOtherProgSrvcRevenueAmt
Total Program Service Expenses$18,912,947TotalProgramServiceExpensesAmt
Described In Section501c3Yes (1)DescribedInSection501c3Ind
Schedule B Required0ScheduleBRequiredInd
Political Campaign Acty0PoliticalCampaignActyInd
Lobbying Activities0LobbyingActivitiesInd
Subject To Proxy Tax0SubjectToProxyTaxInd
Donor Advised Fund0DonorAdvisedFundInd
Conservation Easements0ConservationEasementsInd
Collections Of Art0CollectionsOfArtInd
Credit Counseling0CreditCounselingInd
Donor Rstr Or Quasi Endowments0DonorRstrOrQuasiEndowmentsInd
Report Land Building EquipmentYes (1)ReportLandBuildingEquipmentInd
Report Investments Other Sec0ReportInvestmentsOtherSecInd
Report Program Related Invst0ReportProgramRelatedInvstInd
Report Other Assets0ReportOtherAssetsInd
Report Other LiabilitiesYes (1)ReportOtherLiabilitiesInd
Include FIN48 FootnoteYes (1)IncludeFIN48FootnoteInd
Independent Audit Fincl StmtYes (1)IndependentAuditFinclStmtInd
Consolidated Audit Fincl Stmt0ConsolidatedAuditFinclStmtInd
School Operating0SchoolOperatingInd
Foreign Office0ForeignOfficeInd
Foreign ActivitiesYes (1)ForeignActivitiesInd
More Than5000 K To Org0MoreThan5000KToOrgInd
More Than5000 K To Individuals0MoreThan5000KToIndividualsInd
Professional Fundraising0ProfessionalFundraisingInd
Fundraising Activities0FundraisingActivitiesInd
Gaming Activities0GamingActivitiesInd
Operate Hospital0OperateHospitalInd
Grants To Organizations0GrantsToOrganizationsInd
Grants To Individuals0GrantsToIndividualsInd
Schedule J RequiredYes (1)ScheduleJRequiredInd
Tax Exempt Bonds0TaxExemptBondsInd
Engaged In Excess Benefit Trans0EngagedInExcessBenefitTransInd
PY Excess Benefit Trans0PYExcessBenefitTransInd
Loan Outstanding0LoanOutstandingInd
Grant To Related Person0GrantToRelatedPersonInd
Business Rln With Org Mem0BusinessRlnWithOrgMemInd
Business Rln With Fam Mem0BusinessRlnWithFamMemInd
Business Rln With35 Ctrl Ent0BusinessRlnWith35CtrlEntInd
Deductible Non Cash Contri0DeductibleNonCashContriInd
Deductible Art Contribution0DeductibleArtContributionInd
Terminate Operations0TerminateOperationsInd
Partial Liquidation0PartialLiquidationInd
Disregarded Entity0DisregardedEntityInd
Related Entity0RelatedEntityInd
Related Organization Ctrl Ent0RelatedOrganizationCtrlEntInd
Trnsfr Exmpt Non Chrtbl Rltd Org0TrnsfrExmptNonChrtblRltdOrgInd
Activities Conducted Prtshp0ActivitiesConductedPrtshpInd
Schedule O RequiredYes (1)ScheduleORequiredInd
IRP Document29IRPDocumentCnt
IRP Document W2 G0IRPDocumentW2GCnt
Backup Wthld ComplianceYes (1)BackupWthldComplianceInd
Employee84EmployeeCnt
Employment Tax Returns FiledYes (1)EmploymentTaxReturnsFiledInd
Unrelated Bus Incm Over Limit0UnrelatedBusIncmOverLimitInd
Foreign Financial Account0ForeignFinancialAccountInd
Prohibited Tax Shelter Trans0ProhibitedTaxShelterTransInd
Taxable Party Notification0TaxablePartyNotificationInd
Nondeductible Contributions0NondeductibleContributionsInd
Quid Pro Quo Contributions0QuidProQuoContributionsInd
Form8282 Property Disposed Of0Form8282PropertyDisposedOfInd
Rcv Fnds To Pay Prsnl Bnft Cntrct0RcvFndsToPayPrsnlBnftCntrctInd
Pay Premiums Prsnl Bnft Cntrct0PayPremiumsPrsnlBnftCntrctInd
Indoor Tanning Services0IndoorTanningServicesInd
Subj To Tax Rmnrtn Ex Prcht PymtYes (1)SubjToTaxRmnrtnExPrchtPymtInd
Subject To Excs Tax Net Invst Inc0SubjectToExcsTaxNetInvstIncInd
Info In Schedule O Part VIYes (X)InfoInScheduleOPartVIInd
Governing Body Voting Members5GoverningBodyVotingMembersCnt
Independent Voting Member4IndependentVotingMemberCnt
Family Or Business Rln0FamilyOrBusinessRlnInd
Delegation Of Mgmt Duties0DelegationOfMgmtDutiesInd
Change To Org Documents0ChangeToOrgDocumentsInd
Material Diversion Or Misuse0MaterialDiversionOrMisuseInd
Members Or Stockholders0MembersOrStockholdersInd
Election Of Board Members0ElectionOfBoardMembersInd
Decisions Subject To Approva0DecisionsSubjectToApprovaInd
Minutes Of Governing BodyYes (1)MinutesOfGoverningBodyInd
Minutes Of CommitteesYes (1)MinutesOfCommitteesInd
Officer Mailing Address0OfficerMailingAddressInd
Local Chapters0LocalChaptersInd
Form990 Provided To Gvrn BodyYes (1)Form990ProvidedToGvrnBodyInd
Conflict Of Interest PolicyYes (1)ConflictOfInterestPolicyInd
Annual Disclosure Covered PrsnYes (1)AnnualDisclosureCoveredPrsnInd
Regular Monitoring EnfrcYes (1)RegularMonitoringEnfrcInd
Whistleblower PolicyYes (1)WhistleblowerPolicyInd
Document Retention PolicyYes (1)DocumentRetentionPolicyInd
Compensation Process CEOYes (1)CompensationProcessCEOInd
Compensation Process OtherYes (1)CompensationProcessOtherInd
Investment In Joint VentureYes (1)InvestmentInJointVentureInd
Written Policy Or ProcedureYes (1)WrittenPolicyOrProcedureInd
States Where Copy Of Return Is FldCAStatesWhereCopyOfReturnIsFldCd
Upon RequestYes (X)UponRequestInd

Books In Care Of Detail BooksInCareOfDetail

Business Name BusinessName

FieldValueIRS element (for citing)
Business Name Line1FARAH BOROOMANDBusinessNameLine1Txt
FieldValueIRS element (for citing)
Phone6617026731PhoneNum

US Address USAddress

FieldValueIRS element (for citing)
Address Line125134 RYE CANYON LOOPAddressLine1Txt
CitySANTA CLARITACityNm
State AbbreviationCAStateAbbreviationCd
ZIP91355ZIPCd

Form990 Part VII Section A Form990PartVIISectionAGrp (23 entries)

TitleTitleTxtAverage Hours Per WeekAverageHoursPerWeekRtIndividual Trustee Or DirectorIndividualTrusteeOrDirectorIndOfficerOfficerIndReportable Comp From OrgReportableCompFromOrgAmtReportable Comp From Rltd OrgReportableCompFromRltdOrgAmtOther CompensationOtherCompensationAmtKey EmployeeKeyEmployeeIndHighest Compensated EmployeeHighestCompensatedEmployeeInd
ROBERT GREENBERG
CEO, EXECUTIVE CHAIRMAN OF THE BOARD44.00Yes (X)Yes (X)$1,029,580$0$73,268
KEN WEATHERWAX
BOARD MEMBER1.25Yes (X)$0$0$0
RICHARD WAUGH
BOARD MEMBER1.50Yes (X)$0$0$0
DAVID GILL
BOARD MEMBER1.50Yes (X)$0$0$0
DAVID SCOTT
BOARD MEMBER1.25Yes (X)$0$0$0
FARAH BOROOMAND
CHIEF FINANCIAL OFFICER44.00Yes (X)$516,762$0$34,316
CHARLES NELSON THRU 033123
CHIEF OPERATING OFFICER40.00Yes (X)$390,806$0$40,565
COREY DISHMON
CHIEF LEGAL OFFICER, EXECUTIVE VP, BUSINESS DEVELO40.00Yes (X)$346,412$0$26,430
NEIL TALBOT
VP, RESEARCH AND TECHNOLOGY40.00Yes (X)$318,519$0$38,865
BRIAN MECH
VICE PRESIDENT, STRATEGY40.00Yes (X)$265,049$0$9,346
VALMA KLEIN
VICE PRESIDENT, CLINICAL AFFAIRS41.50Yes (X)$248,003$0$32,306
PHILIP LEE
ASSISTANT GENERAL COUNSEL40.00Yes (X)$207,284$0$13,149
MICHAEL PERRIN THRU 021822
VP QUAL ASSUR, REGULATORY, OPERATIONS40.00Yes (X)$163,685$0$32,824
CEDRIC NAVARRO AS OF 080822
VP, REGULATORY AFFAIRS40.00Yes (X)$70,873$0$17,410
JOHN RIVERA AS OF 032023
VP, PRODUCT DEVELOPMENT40.00Yes (X)$0$0$0
JOSEPH CALDERON
DIRECTOR, MECHANICAL ENGINEERING45.50$247,497$0$44,789Yes (X)
BRIAN SHELTON
DIRECTOR, SOFTWARE AND SYSTEMS DEV40.00$239,705$0$30,378Yes (X)
BRIAN DEARDEN THRU 012023
DIRECTOR, ELECTRICAL ENGINEERING41.00$217,965$0$50,790Yes (X)
CHRISTOPHER FLECK
DIRECTOR, MANUFACTURING ENGINEERING40.00$237,476$0$24,821Yes (X)
CHRISTOPHER JENNEY
SR. PRINCIPAL MATERIALS SCIENTIST40.00$198,781$0$35,798Yes (X)
WILLIAM BRANDT
SR. PRINCIPAL MECHANICAL ENGINEER46.00$200,048$0$14,086Yes (X)
SAM BOWMAN
PRINCIPAL ENGINEER ELECTRICAL40.00$209,380$0$26,206Yes (X)
JEFFREY BRYDLE
FIRMWARE ENGINEERING MANAGER40.00$194,484$0$16,834Yes (X)
FieldValueIRS element (for citing)
Total Reportable Comp From Org$5,302,309TotalReportableCompFromOrgAmt
Tot Reportable Comp Rltd Org$0TotReportableCompRltdOrgAmt
Total Other Compensation$562,181TotalOtherCompensationAmt
Indiv Rcvd Greater Than100 K42IndivRcvdGreaterThan100KCnt
Former Ofcr Employees Listed0FormerOfcrEmployeesListedInd
Total Comp Greater Than150 KYes (1)TotalCompGreaterThan150KInd
Compensation From Other Srcs0CompensationFromOtherSrcsInd

Contractor Compensation ContractorCompensationGrp (5 entries)

Address Line1ContractorAddress/USAddress/AddressLine1TxtCityContractorAddress/USAddress/CityNmState AbbreviationContractorAddress/USAddress/StateAbbreviationCdZIPContractorAddress/USAddress/ZIPCdServicesServicesDescCompensationCompensationAmt
MEDIX STAFFING SOLUTIONS INC
222 S RIVERSIDE PLAZA SUITE 2120CHICAGOIL60606TEMPORARY EMPLOYMENT SERVCIES$353,054
LEWIS ROCA ROTHGERBER CHRISTIE LLP
201 EAST WASHINGTON STREETPHOENIXAZ85004LEGAL SERVICES$275,374
PRD CONSTRUCTION INC
16843 SIERRA HIGHWAYCANYON COUNTRYCA91351BUILDING / LEASE HOLD IMPROVEMENT$249,146
COMPUTER PACKAGES INC
11 N WASHINGTON STREET SUITE 300ROCKVILLEMD20850SOFTWARE PROVIDERS$167,974
NORTH AMERICAN SCIENCE ASSOCIATES LLC-MN
8945 EVERGREEN BLVD NWMINNEAPOLISMN55433RESEARCH AND DEVELOPMENT PROJECT$166,979
FieldValueIRS element (for citing)
Cntrct Rcvd Greater Than100 K18CntrctRcvdGreaterThan100KCnt
All Other Contributions$805AllOtherContributionsAmt
Total Contributions$805TotalContributionsAmt

Program Service Revenue ProgramServiceRevenueGrp (3 entries)

DescDescBusinessBusinessCdTotal Revenue ColumnTotalRevenueColumnAmtRelated Or Exempt Func IncomeRelatedOrExemptFuncIncomeAmt
OTHER PROJECT INCOME (OSSUR)541700$701,650$701,650
IMES II PROGRAM REVENUE541700$104,201$104,201
RESEARCH GRANT INCOME541700$56,470$56,470
FieldValueIRS element (for citing)
Total Program Service Revenue$862,321TotalProgramServiceRevenueAmt

Investment Income InvestmentIncomeGrp

FieldValueIRS element (for citing)
Total Revenue Column$7,726,554TotalRevenueColumnAmt
Exclusion$7,726,554ExclusionAmt

Royalties Revenue RoyaltiesRevenueGrp

FieldValueIRS element (for citing)
Total Revenue Column$2,172,096TotalRevenueColumnAmt
Related Or Exempt Func Income$2,172,096RelatedOrExemptFuncIncomeAmt

Gross Amount Sales Assets GrossAmountSalesAssetsGrp

FieldValueIRS element (for citing)
Securities$22,763,482SecuritiesAmt
Other$10,000OtherAmt

Less Cost Oth Basis Sales Expnss LessCostOthBasisSalesExpnssGrp

FieldValueIRS element (for citing)
Securities$2,472,182SecuritiesAmt
Other$9,034OtherAmt

Gain Or Loss GainOrLossGrp

FieldValueIRS element (for citing)
Securities$20,291,300SecuritiesAmt
Other$966OtherAmt

Net Gain Or Loss Investments NetGainOrLossInvestmentsGrp

FieldValueIRS element (for citing)
Total Revenue Column$20,292,266TotalRevenueColumnAmt
Exclusion$20,292,266ExclusionAmt

Total Revenue TotalRevenueGrp

FieldValueIRS element (for citing)
Total Revenue Column$31,054,042TotalRevenueColumnAmt
Related Or Exempt Func Income$3,034,417RelatedOrExemptFuncIncomeAmt
Unrelated Business Revenue$0UnrelatedBusinessRevenueAmt
Exclusion$28,018,820ExclusionAmt
FieldValueIRS element (for citing)
Info In Schedule O Part IXYes (X)InfoInScheduleOPartIXInd

Grants To Domestic Orgs GrantsToDomesticOrgsGrp

FieldValueIRS element (for citing)
Total$5,000TotalAmt
Program Services$5,000ProgramServicesAmt

Comp Current Ofcr Directors CompCurrentOfcrDirectorsGrp

FieldValueIRS element (for citing)
Total$4,818,834TotalAmt
Program Services$4,016,042ProgramServicesAmt
Management And General$802,792ManagementAndGeneralAmt

Other Salaries And Wages OtherSalariesAndWagesGrp

FieldValueIRS element (for citing)
Total$7,062,906TotalAmt
Program Services$6,147,314ProgramServicesAmt
Management And General$915,592ManagementAndGeneralAmt

Pension Plan Contributions PensionPlanContributionsGrp

FieldValueIRS element (for citing)
Total$120,770TotalAmt
Program Services$84,650ProgramServicesAmt
Management And General$36,120ManagementAndGeneralAmt

Other Employee Benefits OtherEmployeeBenefitsGrp

FieldValueIRS element (for citing)
Total$984,021TotalAmt
Program Services$915,064ProgramServicesAmt
Management And General$68,957ManagementAndGeneralAmt

Payroll Taxes PayrollTaxesGrp

FieldValueIRS element (for citing)
Total$701,551TotalAmt
Program Services$609,381ProgramServicesAmt
Management And General$92,170ManagementAndGeneralAmt

Fees For Services Legal FeesForServicesLegalGrp

FieldValueIRS element (for citing)
Total$740,519TotalAmt
Program Services$672,593ProgramServicesAmt
Management And General$67,926ManagementAndGeneralAmt

Fees For Services Accounting FeesForServicesAccountingGrp

FieldValueIRS element (for citing)
Total$104,331TotalAmt
Management And General$104,331ManagementAndGeneralAmt

Fees For Srvc Invst Mgmnt Fees FeesForSrvcInvstMgmntFeesGrp

FieldValueIRS element (for citing)
Total$1,089,834TotalAmt
Management And General$1,089,834ManagementAndGeneralAmt

Fees For Services Other FeesForServicesOtherGrp

FieldValueIRS element (for citing)
Total$2,437,275TotalAmt
Program Services$2,410,564ProgramServicesAmt
Management And General$26,711ManagementAndGeneralAmt

Office Expenses OfficeExpensesGrp

FieldValueIRS element (for citing)
Total$1,844,486TotalAmt
Program Services$1,783,001ProgramServicesAmt
Management And General$61,485ManagementAndGeneralAmt

Information Technology InformationTechnologyGrp

FieldValueIRS element (for citing)
Total$361,162TotalAmt
Program Services$348,307ProgramServicesAmt
Management And General$12,855ManagementAndGeneralAmt

Occupancy OccupancyGrp

FieldValueIRS element (for citing)
Total$1,204,384TotalAmt
Program Services$998,168ProgramServicesAmt
Management And General$206,216ManagementAndGeneralAmt

Travel TravelGrp

FieldValueIRS element (for citing)
Total$125,053TotalAmt
Program Services$98,868ProgramServicesAmt
Management And General$26,185ManagementAndGeneralAmt

Conferences Meetings ConferencesMeetingsGrp

FieldValueIRS element (for citing)
Total$61,855TotalAmt
Program Services$35,141ProgramServicesAmt
Management And General$26,714ManagementAndGeneralAmt

Depreciation Depletion DepreciationDepletionGrp

FieldValueIRS element (for citing)
Total$688,556TotalAmt
Program Services$604,089ProgramServicesAmt
Management And General$84,467ManagementAndGeneralAmt

Insurance InsuranceGrp

FieldValueIRS element (for citing)
Total$103,794TotalAmt
Program Services$89,707ProgramServicesAmt
Management And General$14,087ManagementAndGeneralAmt

Other Expenses OtherExpensesGrp (4 entries)

DescDescTotalTotalAmtProgram ServicesProgramServicesAmtManagement And GeneralManagementAndGeneralAmt
RELOCATION EXPENSE$290,516$30,589$259,927
EMPLOYEE MORALE$56,376$47,488$8,888
EMPLOYEE TRAINING$11,016$9,310$1,706
MEALS$6,995$4,671$2,324

All Other Expenses AllOtherExpensesGrp

FieldValueIRS element (for citing)
Total$3,000TotalAmt
Program Services$3,000ProgramServicesAmt

Total Functional Expenses TotalFunctionalExpensesGrp

FieldValueIRS element (for citing)
Total$22,822,234TotalAmt
Program Services$18,912,947ProgramServicesAmt
Management And General$3,909,287ManagementAndGeneralAmt
Fundraising$0FundraisingAmt

Cash Non Interest Bearing CashNonInterestBearingGrp

FieldValueIRS element (for citing)
BOY$1,040,546BOYAmt
EOY$222,920EOYAmt

Savings And Temp Cash Invst SavingsAndTempCashInvstGrp

FieldValueIRS element (for citing)
BOY$118,586,920BOYAmt
EOY$113,006,676EOYAmt

Accounts Receivable AccountsReceivableGrp

FieldValueIRS element (for citing)
BOY$6,079BOYAmt
EOY$2,066EOYAmt

Prepaid Expenses Defrd Charges PrepaidExpensesDefrdChargesGrp

FieldValueIRS element (for citing)
BOY$512,509BOYAmt
EOY$185,245EOYAmt
FieldValueIRS element (for citing)
Land Bldg Equip Cost Or Other Bss$8,739,760LandBldgEquipCostOrOtherBssAmt
Land Bldg Equip Accum Deprec$6,351,485LandBldgEquipAccumDeprecAmt

Land Bldg Equip Basis Net LandBldgEquipBasisNetGrp

FieldValueIRS element (for citing)
BOY$1,619,855BOYAmt
EOY$2,388,275EOYAmt

Investments Pub Traded Sec InvestmentsPubTradedSecGrp

FieldValueIRS element (for citing)
BOY$241,873,349BOYAmt
EOY$224,021,417EOYAmt

Investments Other Securities InvestmentsOtherSecuritiesGrp

FieldValueIRS element (for citing)
BOY$1,477,043BOYAmt
EOY$138,767EOYAmt

Intangible Assets IntangibleAssetsGrp

FieldValueIRS element (for citing)
BOY$919,507BOYAmt
EOY$842,965EOYAmt

Other Assets Total OtherAssetsTotalGrp

FieldValueIRS element (for citing)
BOY$8,308,167BOYAmt
EOY$3,871,886EOYAmt

Total Assets TotalAssetsGrp

FieldValueIRS element (for citing)
BOY$374,343,975BOYAmt
EOY$344,680,217EOYAmt

Accounts Payable Accr Expnss AccountsPayableAccrExpnssGrp

FieldValueIRS element (for citing)
BOY$2,647,791BOYAmt
EOY$2,739,571EOYAmt

Other Liabilities OtherLiabilitiesGrp

FieldValueIRS element (for citing)
BOY$0BOYAmt
EOY$3,257,152EOYAmt

Total Liabilities TotalLiabilitiesGrp

FieldValueIRS element (for citing)
BOY$2,647,791BOYAmt
EOY$5,996,723EOYAmt
FieldValueIRS element (for citing)
Organization Follows FASB117Yes (X)OrganizationFollowsFASB117Ind

No Donor Restriction Net Assets NoDonorRestrictionNetAssetsGrp

FieldValueIRS element (for citing)
BOY$371,696,184BOYAmt
EOY$338,683,494EOYAmt

Total Net Assets Fund Balance TotalNetAssetsFundBalanceGrp

FieldValueIRS element (for citing)
BOY$371,696,184BOYAmt
EOY$338,683,494EOYAmt

Tot Liab Net Assets Fund Balance TotLiabNetAssetsFundBalanceGrp

FieldValueIRS element (for citing)
BOY$374,343,975BOYAmt
EOY$344,680,217EOYAmt
FieldValueIRS element (for citing)
Reconcilation Revenue Expnss$8,231,808ReconcilationRevenueExpnssAmt
Net Unrlzd Gains Losses Invst-$41,244,498NetUnrlzdGainsLossesInvstAmt
Other Changes In Net Assets$0OtherChangesInNetAssetsAmt
Method Of Accounting AccrualYes (X)MethodOfAccountingAccrualInd
Accountant Compile Or Review0AccountantCompileOrReviewInd
FS AuditedYes (1)FSAuditedInd

FS Audited Basis FSAuditedBasisGrp

FieldValueIRS element (for citing)
Separate Basis Fincl StmtYes (X)SeparateBasisFinclStmtInd
FieldValueIRS element (for citing)
Audit CommitteeYes (1)AuditCommitteeInd
Federal Grant Audit Required0FederalGrantAuditRequiredInd

Schedule A IRS990ScheduleA

FieldValueIRS element (for citing)
Medical Research OrganizationYes (X)MedicalResearchOrganizationInd

Hospital Name And Address HospitalNameAndAddressGrp

Supported Organization Name SupportedOrganizationName

FieldValueIRS element (for citing)
Business Name Line1UCLA FOUNDATIONBusinessNameLine1Txt
FieldValueIRS element (for citing)
CityLOS ANGELESCityNm
State AbbreviationCAStateAbbreviationCd

Schedule D IRS990ScheduleD

Leasehold Improvements LeaseholdImprovementsGrp

FieldValueIRS element (for citing)
Other Cost Or Other Basis$1,470,564OtherCostOrOtherBasisAmt
Depreciation$912,102DepreciationAmt
Book Value$558,462BookValueAmt

Equipment EquipmentGrp

FieldValueIRS element (for citing)
Other Cost Or Other Basis$5,650,123OtherCostOrOtherBasisAmt
Depreciation$4,185,804DepreciationAmt
Book Value$1,464,319BookValueAmt

Other Land Buildings OtherLandBuildingsGrp

FieldValueIRS element (for citing)
Other Cost Or Other Basis$1,619,073OtherCostOrOtherBasisAmt
Depreciation$1,253,579DepreciationAmt
Book Value$365,494BookValueAmt
FieldValueIRS element (for citing)
Total Book Value Land Buildings$2,388,275TotalBookValueLandBuildingsAmt

Other Liabilities Org OtherLiabilitiesOrgGrp

FieldValueIRS element (for citing)
DescOPERATING LEASE LIABILITIESDesc
Amt$3,257,152Amt
FieldValueIRS element (for citing)
Total Liability$3,257,152TotalLiabilityAmt
Footnote TextYes (X)FootnoteTextInd
Total Rev Etc Audited Fincl Stmt-$10,190,456TotalRevEtcAuditedFinclStmtAmt
Net Unrealized Gains Invst-$41,244,498NetUnrealizedGainsInvstAmt
Revenue Not Reported-$41,244,498RevenueNotReportedAmt
Revenue Subtotal$31,054,042RevenueSubtotalAmt
Revenue Not Reported Fincl Stmt$0RevenueNotReportedFinclStmtAmt
Total Revenue Per Form990$31,054,042TotalRevenuePerForm990Amt
Tot Expns Etc Audited Fincl Stmt$22,822,234TotExpnsEtcAuditedFinclStmtAmt
Expenses Not Reported$0ExpensesNotReportedAmt
Expenses Subtotal$22,822,234ExpensesSubtotalAmt
Expenses Not Rpt Fincl Stmt$0ExpensesNotRptFinclStmtAmt
Total Expenses Per Form990$22,822,234TotalExpensesPerForm990Amt

Supplemental Information Detail SupplementalInformationDetail

FieldValueIRS element (for citing)
Form And Line ReferencePART X, LINE 2:FormAndLineReferenceDesc
ExplanationTHE ALFRED E. MANN FOUNDATION FOR SCIENTIFIC RESEARCH IS EXEMPT FROM FEDERAL INCOME AND CALIFORNIA FRANCHISE TAXES UNDER SECTION 501(C)(3) OF THE INTERNAL REVENUE CODE AND THE CORRESPONDING CALIFORNIA PROVISIONS. THE ALFRED E. MANN FOUNDATION FOR SCIENTIFIC RESEARCH HAD NO SIGNIFICANT UNRELATED BUSINESS INCOME TAX DURING THE YEAR ENDED MARCH 31, 2023 AND 2022. ACCORDINGLY, NO TAX PROVISION FOR UNRELATED BUSINESS INCOME HAS BEEN MADE IN THE ACCOMPANYING FINANCIAL STATEMENTS FOR 2023 AND 2022. THE FOUNDATION, UNDER THE PROVISIONS OF ASC 740, INCOME TAXES, HAD NO UNCERTAIN TAX POSITIONS REQUIRING ACCRUAL AS OF MARCH 31, 2023 AND 2022.ExplanationTxt

Schedule F IRS990ScheduleF

Account Activities Outside US AccountActivitiesOutsideUSGrp (2 entries)

RegionRegionTxtOfficesOfficesCntEmployeeEmployeeCntType Of Activities ConductedTypeOfActivitiesConductedTxtRegion Total ExpendituresRegionTotalExpendituresAmt
CENTRAL AMERICA AND THE CARIBBEAN00INVESTMENTS$20,920,068
NORTH AMERICA00INVESTMENTS$173,271
FieldValueIRS element (for citing)
Subtotal Offices0SubtotalOfficesCnt
Subtotal Employees0SubtotalEmployeesCnt
Continuation Total Office0ContinuationTotalOfficeCnt
Continuation Total Employee0ContinuationTotalEmployeeCnt
Total Office0TotalOfficeCnt
Total Employee0TotalEmployeeCnt
Subtotal Spent$21,093,339SubtotalSpentAmt
Continuation Spent$0ContinuationSpentAmt
Total Spent$21,093,339TotalSpentAmt
Transfer To Foreign CorpYes (1)TransferToForeignCorpInd
Interest In Foreign Trust0InterestInForeignTrustInd
Foreign Corp OwnershipYes (1)ForeignCorpOwnershipInd
Passive Foreign Investmest CoYes (1)PassiveForeignInvestmestCoInd
Foreign PartnershipYes (1)ForeignPartnershipInd
Boycott Countries0BoycottCountriesInd

Supplemental Information Detail SupplementalInformationDetail (2 entries)

Form And Line ReferenceFormAndLineReferenceDescExplanationExplanationTxt
PART I, LINE 3:THE ACCRUAL METHOD OF ACCOUNTING IS USED FOR BOTH AMOUNTS REPORTED AS INVESTMENTS AND EXPENDITURES.
PART III ACCOUNTING METHOD:

Schedule J IRS990ScheduleJ

FieldValueIRS element (for citing)
Independent ConsultantYes (X)IndependentConsultantInd
Compensation SurveyYes (X)CompensationSurveyInd
Board Or Committee ApprovalYes (X)BoardOrCommitteeApprovalInd
Severance PaymentYes (1)SeverancePaymentInd
Supplemental Nonqual Rtr Plan0SupplementalNonqualRtrPlanInd
Equity Based Comp Arrngm0EquityBasedCompArrngmInd
Comp Based On Revenue Of Flng OrgYes (1)CompBasedOnRevenueOfFlngOrgInd
Comp Bsd On Rev Related Orgs0CompBsdOnRevRelatedOrgsInd
Comp Bsd Net Earns Flng Org0CompBsdNetEarnsFlngOrgInd
Comp Bsd Net Earns Rltd Orgs0CompBsdNetEarnsRltdOrgsInd
Any Non Fixed PaymentsYes (1)AnyNonFixedPaymentsInd
Initial Contract Exception0InitialContractExceptionInd

Rltd Org Officer Trst Key Empl RltdOrgOfficerTrstKeyEmplGrp (17 entries)

TitleTitleTxtBase Compensation Filing OrgBaseCompensationFilingOrgAmtCompensation Based On Rltd OrgsCompensationBasedOnRltdOrgsAmtBonus Filing OrganizationBonusFilingOrganizationAmountBonus Related OrganizationsBonusRelatedOrganizationsAmtOther Compensation Filing OrgOtherCompensationFilingOrgAmtOther Compensation Rltd OrgsOtherCompensationRltdOrgsAmtDeferred Compensation Flng OrgDeferredCompensationFlngOrgAmtDeferred Comp Rltd OrgsDeferredCompRltdOrgsAmtNontaxable Benefits Filing OrgNontaxableBenefitsFilingOrgAmtNontaxable Benefits Rltd OrgsNontaxableBenefitsRltdOrgsAmtTotal Compensation Filing OrgTotalCompensationFilingOrgAmtTotal Compensation Rltd OrgsTotalCompensationRltdOrgsAmtComp Report Prior990 Filing OrgCompReportPrior990FilingOrgAmtComp Report Prior990 Rltd OrgsCompReportPrior990RltdOrgsAmt
ROBERT GREENBERG
CEO, EXECUTIVE CHAIRMAN OF THE BOARD$539,580$0$490,000$0$0$0$9,150$0$64,118$0$1,102,848$0$0$0
FARAH BOROOMAND
CHIEF FINANCIAL OFFICER$317,807$0$198,955$0$0$0$9,029$0$25,287$0$551,078$0$0$0
CHARLES NELSON THRU 033123
CHIEF OPERATING OFFICER$327,306$0$63,500$0$0$0$9,150$0$31,415$0$431,371$0$0$0
COREY DISHMON
CHIEF LEGAL OFFICER, EXECUTIVE VP, B$288,412$0$58,000$0$0$0$6,174$0$20,256$0$372,842$0$0$0
NEIL TALBOT
VP, RESEARCH AND TECHNOLOGY$257,894$0$60,625$0$0$0$7,831$0$31,034$0$357,384$0$0$0
JOSEPH CALDERON
DIRECTOR, MECHANICAL ENGINEERING$171,157$0$76,340$0$0$0$6,485$0$38,304$0$292,286$0$0$0
VALMA KLEIN
VICE PRESIDENT, CLINICAL AFFAIRS$189,378$0$58,625$0$0$0$5,854$0$26,452$0$280,309$0$0$0
BRIAN MECH
VICE PRESIDENT, STRATEGY$255,039$0$10,010$0$0$0$8,008$0$1,338$0$274,395$0$0$0
BRIAN SHELTON
DIRECTOR, SOFTWARE AND SYSTEMS DEV$188,345$0$51,360$0$0$0$5,730$0$24,648$0$270,083$0$0$0
BRIAN DEARDEN THRU 012023
DIRECTOR, ELECTRICAL ENGINEERING$183,875$0$34,090$0$0$0$5,455$0$45,335$0$268,755$0$0$0
CHRISTOPHER FLECK
DIRECTOR, MANUFACTURING ENGINEERING$194,766$0$42,710$0$0$0$6,314$0$18,507$0$262,297$0$0$0
SAM BOWMAN
PRINCIPAL ENGINEER ELECTRICAL$168,170$0$41,210$0$0$0$4,706$0$21,500$0$235,586$0$0$0
CHRISTOPHER JENNEY
SR. PRINCIPAL MATERIALS SCIENTIST$167,371$0$31,410$0$0$0$5,108$0$30,690$0$234,579$0$0$0
PHILIP LEE
ASSISTANT GENERAL COUNSEL$181,784$0$25,500$0$0$0$5,070$0$8,079$0$220,433$0$0$0
WILLIAM BRANDT
SR. PRINCIPAL MECHANICAL ENGINEER$153,848$0$46,200$0$0$0$5,375$0$8,711$0$214,134$0$0$0
JEFFREY BRYDLE
FIRMWARE ENGINEERING MANAGER$181,349$0$13,135$0$0$0$5,899$0$10,935$0$211,318$0$0$0
MICHAEL PERRIN THRU 021822
VP QUAL ASSUR, REGULATORY, OPERATION$54,747$0$32,749$0$76,189$0$990$0$31,834$0$196,509$0$0$0

Supplemental Information Detail SupplementalInformationDetail (3 entries)

Form And Line ReferenceFormAndLineReferenceDescExplanationExplanationTxt
PART I, LINE 4AMICHAEL PERRIN RECEIVED A SEVERANCE PAYMENT OF $76,189 DURING CALENDAR YEAR 2022.
PART I, LINE 5AWARDS WERE PAID THIS YEAR UNDER TWO INCENTIVE COMPENSATION PLANS KNOWN AS THE ALFRED MANN FOUNDATION FOR SCIENTIFIC RESEARCH INCENTIVE COMPENSATION PLAN AXONICS MODULATION TECHNOLOGIES AND B) THE DEFERRED COMPENSATION PLAN RE: MEDTRONIC TRANSACTION. THE AXONICS INCENTIVE WILL CONTINUE UPON THE RECEIPT BY AMF FROM AXONICS QUARTERLY ROYALTIES UNDER A LICENSE AGREEMENT BETWEEN AMF AND AXONICS COVERING CERTAIN AMF PATENTS AND OTHER INTELLECTUAL PROPERTY LICENSED TO AXONICS TILL THE EXPIRATION OF THE PATENTS. THE MEDTRONIC DRFFERED COMP INCENTIVE WILL CONTINUE FOR THE NEXT 3 YEARS. AS STATED IN THE PLAN, "THE PURPOSE OF THESE PLANS IS TO ENHANCE THE ABILITY OF AMF TO ATTRACT AND RETAIN HIGHLY QUALIFIED EMPLOYEES BY PROVIDING INCENTIVE COMPENSATION OPPORTUNITIES. TO THE EXTENT THE PLANS PROVIDE FOR A DEFERRAL OF COMPENSATION, THE PLANS ARE INTENDED TO BE INELIGIBLE DEFERRED COMPENSATION PLANS WITHIN THE MEANING OF SECTION 457(F) OF THE INTERNAL REVENUE CODE OF 1986, AS AMENDED (THE "CODE")." THESE PLANS ARE INTENDED TO BE A NONQUALIFIED DEFERRED COMPENSATION PLAN WITHIN THE MEANING OF CODE SECTION 457(F), AND AS SUCH PARTICIPATION IS LIMITED TO EMPLOYEES WHO (I) QUALIFY FOR INCLUSION IN A SELECT GROUP OF MANAGEMENT OR HIGHLY COMPENSATED EMPLOYEES" WITHIN THE MEANING OF ERISA SECTIONS 201(2), 301(A)(3) AND 401(A)(1), AND (II) ARE DESIGNATED BY THE COMMITTEE TO BE ELIGIBLE FOR A COMPENSATION AWARD. EMPLOYEES DESIGNATED TO RECEIVE AWARDS ENTER INTO AN INDIVIDUAL AWARD AGREEMENTS UNDER THE PLAN. PLAN AWARDS PROVIDE LONG-TERM, DEFERRED INCENTIVE COMPENSATION TO AWARD RECIPIENTS MEANT TO SERVE AS A GENERAL EMPLOYEE RETENTION TOOL, AND ALSO TO REWARD KEY PARTICIPANTS IN THE UNDERLYING PROJECT OR RESEARCH EFFORT THAT WAS THE SUBJECT OF THE LTIPS. UPON ACTUAL RECEIPT BY AMF OF PROCEEDS OF A LIQUIDITY EVENT (AND AFTER DEDUCTING CERTAIN AMOUNTS DESIGNED TO REIMBURSE AMF FOR ITS COSTS OF THE UNDERLYING ASSET), AN AWARD POOL IS CREATED AND AWARD RECIPIENTS ARE PAID A PERCENTAGE OF THE NET PROCEEDS RECEIVED BY AMF. TYPICALLY, THE TOTAL AWARDS TO ALL RECIPIENTS IN ANY PLAN DO NOT EXCEED 12.00% OF THE AMOUNT OF NET PROCEEDS REALIZED BY AMF. NO AMOUNTS ARE PAYABLE UNLESS AND UNTIL AMF HAS ACTUALLY RECEIVED THE PROCEEDS OF A LIQUIDITY EVENT OR ROYALTIES UNDER THE LICENSE AGREEMENT. THE AWARDS ARE SUBJECT TO SEVERAL CONDITIONS, DESIGNED TO PROVIDE A SUBSTANTIAL RISK OF FORFEITURE TO THE AWARD RECIPIENT. AMONG THESE CONDITIONS AND RISKS ARE: - THE RISK OF FORFEITURE IF THE RECIPIENT LEAVES THE EMPLOY OF AMF OR IS TERMINATED PRIOR TO VESTING (THERE IS A VESTING PERIOD FOR THE AWARDS, AND AWARDS FURTHER DO NOT VEST EVEN DURING THE PERIOD TO THE EXTENT THAT A LIQUIDITY EVENT SHALL NOT HAVE YET OCCURRED). THERE ARE VERY LIMITED EXCEPTIONS FOR RETIREMENT, DEATH AND DISABILITY. - THE RISK THAT THE PROCEEDS OF A LIQUIDITY EVENT WILL FAIL TO EXCEED PREDETERMINED COST REIMBURSEMENT HURDLES THAT ARE BUILT INTO EACH AWARD AGREEMENT. - THE RISK THAT THE UNDERLYING PROJECT OR SPINOUT COMPANY FAILS TO ACHIEVE A LIQUIDITY EVENT AT ALL. - THERE ARE ANNUAL AND CUMULATIVE CAPS TO THE PAYMENT OF AWARDS UNDER THE AWARD AGREEMENT. - RESTRICTIONS SET FORTH IN EACH AWARD AGREEMENT LIMIT THE MAXIMUM AMOUNT OF PROCEEDS TO WHICH A RECIPIENT'S AWARD PERCENTAGE WILL APPLY. THE PLANS AND THE AWARD AGREEMENTS WERE APPROVED BY THE BOARD OF DIRECTORS AFTER REVIEWING DETAILED COMPENSATION ANALYSIS INFORMATION PREPARED BY AN INDEPENDENT NATIONAL FIRM AND RECEIVING OUTSIDE LEGAL ADVICE, BOTH RELATING TO THE REASONABLENESS OF THE LTIP COMPENSATION. THE LTIPS REQUIRE THAT THIS COMPENSATION ANALYSIS BE UPDATED AT LEAST EVERY TWO YEARS, AND THIS WAS DONE IN 2016, 2018, 2020, 2021 AND MOST RECENTLY IN 2023.
PART I, LINE 7TWO ANNUAL BONUSES ARE PAID PURSUANT TO: #1, "THE ALFRED E. MANN FOUNDATION FOR SCIENTIFIC RESEARCH ANNUAL INCENTIVE PLAN AND #2, "THE ALFRED E. MANN FOUNDATION FOR SCIENTIFIC RESEARCH KEY CONTRIBUTOR AWARD PROGRAM". THEY ARE BOTH RENEWED AND APPROVED EACH YEAR BY THE BOARD OF DIRECTORS. "THE ALFRED E. MANN FOUNDATION FOR SCIENTIFIC RESEARCH ANNUAL INCENTIVE PLAN" IS BASED ON THE ACHIEVEMENT OF PERSONAL AND CORPORATE GOALS, AMONG OTHER CONSIDERATIONS, WHILE "THE ALFRED E. MANN FOUNDATION FOR SCIENTIFIC RESEARCH KEY CONTRIBUTOR AWARD PROGRAM" IS TO PROVIDE PERFORMANCE AND RETENTION INCENTIVES BASED ON INDIVIDUAL AND FOUNDATION-WIDE PERFORMANCE TO ELIGIBLE EMPLOYEES OF THE FOUNDATION.

Schedule O IRS990ScheduleO

Supplemental Information Detail SupplementalInformationDetail (5 entries)

Form And Line ReferenceFormAndLineReferenceDescExplanationExplanationTxt
FORM 990, PART VI, SECTION B, LINE 11BA DRAFT OF THE 990 WILL BE PRESENTED BY MANAGEMENT TO THE AUDIT COMMITTEE OF THE BOARD OF DIRECTORS FOR THEIR REVIEW AND DISCUSSION. A FULL COPY OF THE FORM WILL BE PROVIDED TO ALL VOTING MEMBERS PRIOR TO FILING WITH THE IRS.
FORM 990, PART VI, SECTION B, LINE 12CCONFLICT OF INTEREST DISCLOSURES ARE UPDATED ANNUALLY AND POTENTIAL CONFLICTS ARE REVIEWED PRIOR TO PARTICIPATING IN TRANSACTIONS. IF A CONFLICT EXISTS, THE PERSON WITH A CONFLICT DOES NOT VOTE.
FORM 990, PART VI, SECTION B, LINE 15THE BOARD OF DIRECTORS REVIEWS AND APPROVES THE COMPENSATION OF THE CEO AND HIS DIRECT REPORTS INCLUDING THE CFO. IT ALSO REVIEWS AND APPROVES THE OVERALL ANNUAL ADJUSTMENTS TO COMPENSATION OF OTHER EMPLOYEES. SPECIFIC ADJUSTMENTS FOR OTHER EMPLOYEES ARE HANDLED BY THE CEO AND HEAD OF HUMAN RESOURCES USING COMPARISONS TO SALARY SURVEYS FOR SIMILAR POSITIONS AND EXPERIENCE. THE BOARD OF DIRECTORS APPROVED COMPENSATION FOR THE CEO AND HIS DIRECT REPORTS INCLUDING THE CFO ON 6/9/23. THIS PROCESS WAS DOCUMENTED AND USED DETAILED INFORMATION FROM AN INDEPENDENT NATIONAL EXECUTIVE COMPENSATION ANALYSIS FIRM.
FORM 990, PART VI, SECTION C, LINE 19MEMBERS OF THE PUBLIC OR INTERESTED PARTIES MAY REQUEST TO REVIEW OR RECEIVE A COPY OF THE GOVERNING DOCUMENTS, CONFLICT OF INTEREST POLICY, AND FINANCIAL STATEMENTS BY PHONE OR MAIL.
FORM 990, PART IX, LINE 11GCONSULTING FEES: PROGRAM SERVICE EXPENSES 2,410,564. MANAGEMENT AND GENERAL EXPENSES 26,711. FUNDRAISING EXPENSES 0. TOTAL EXPENSES 2,437,275.

Comments

Anonymous: no account or email. Up to 2,000 characters, at most one link. Comments are checked automatically; some wait for review.